Pharma Regulation Panel to Explore Potential Criteria for All-Case PMS Requirement

MHLW Pharma Regulation Panel on Jan. 12 A health ministry study group on pharmaceutical regulations on January 12 discussed issues around the current post-marketing surveillance (PMS) scheme in Japan, including all-case PMS. With all-case PMS quite often required for newly...read more